MCID: PRT036
MIFTS: 60

Peritonitis

Categories: Rare diseases, Gastrointestinal diseases

Aliases & Classifications for Peritonitis

MalaCards integrated aliases for Peritonitis:

Name: Peritonitis 12 52 14 69
Retractile Mesenteritis 12 50 69
Sclerosing Mesenteritis 12 50 69
Peritoneal Retractile Mesenteritis 50 69
Acute Generalized Peritonitis 12 69
Primary Bacterial Peritonitis 12 69
Mesenteric Panniculitis 50 69
Idiopathic Sclerosing Mesenteritis 50
Liposclerotic Mesenteritis 50
Mesenteric Lipodystrophy 50
Mesenteric Lipogranuloma 50
Mesenteric Fibromatosis 50
Fibromatosis, Abdominal 69

Classifications:



External Ids:

Disease Ontology 12 DOID:8283
ICD9CM 35 567.8 567.89
SNOMED-CT 64 197183001 197187000
ICD10 33 K65 K65.9
UMLS 69 C0029823

Summaries for Peritonitis

NIH Rare Diseases : 50 sclerosing mesenteritis is one of many terms that describes a spectrum of inflammatory disorders that affect the mesentery. the mesentery is the membrane that anchors the small intestine to the back of the abdominal wall. the condition mostly affects men between their 40s and 60s, but women and children can also be affected. it may result in a variety of symptoms including abdominal pain, nausea and vomiting, constipation or diarrhea, weight loss, and fever. some people have an abdominal mass. the cause of the condition is poorly understood. suggested possible causes have included previous abdominal surgery or trauma, autoimmunity, paraneoplastic syndromes, ischemic injury, and infection. treatment depends on the symptoms in each person and may include the use of glucocorticoids, hormonal therapy (tamoxifen or progesterone), or other medications, either alone or in combination (i.e. glucocorticoids in combination with tamoxifen). surgery may be needed for an obstruction, if present. although there are case reports of patients with aggressive disease and fatalities, it appears that the condition usually remains stable or is slowly progessive. in some cases, the condition goes away on its own. last updated: 7/24/2017

MalaCards based summary : Peritonitis, also known as retractile mesenteritis, is related to calciphylaxis and acute pancreatitis. An important gene associated with Peritonitis is ALB (Albumin), and among its related pathways/superpathways are Innate Immune System and TGF-Beta Pathway. The drugs Ertapenem and Mupirocin have been mentioned in the context of this disorder. Affiliated tissues include liver, colon and endothelial, and related phenotypes are Synthetic lethal with MLN4924 (a NAE inhibitor) and cardiovascular system

Disease Ontology : 12 A gastrointestinal system disease that involves inflammation of the peritoneum resulting from perforation of the gastrointestinal tract, which produces immediate chemical inflammation followed shortly by infection from intestinal organisms. Peritonitis can also result from appendicitis, diverticulitis, strangulating intestinal obstruction, pancreatitis, pelvic inflammatory disease, mesenteric ischemia, intraperitoneal blood, barium, or peritoneo-systemic shunts, drains, and dialysis catheters in the peritoneal cavity. The symptoms include abdominal pain and tenderness, fever, fluid in the abdomen, nausea, vomiting and low urine output.

Wikipedia : 72 Peritonitis is an inflammation of the peritoneum, the thin tissue that lines the inner wall of the... more...

Related Diseases for Peritonitis

Diseases related to Peritonitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 946)
id Related Disease Score Top Affiliating Genes
1 calciphylaxis 30.5 ALB AQP1 IL1B IL6
2 acute pancreatitis 30.2 CCL2 CXCL8 IL1B IL6 MUC16
3 carbuncle 30.2 CXCL8 IL1B IL6
4 hemolytic-uremic syndrome 30.1 ALB F2 TNF
5 meckel's diverticulum 30.1 ALB CRP F2
6 cataract 30.0 ALB IL1B TNF
7 hyperaldosteronism 30.0 CCL2 ICAM1 IL6
8 capillary leak syndrome 30.0 ALB CRP CXCL8
9 pulmonary tuberculosis 30.0 CCL2 CXCL8 TNF
10 pasteurellosis 30.0 CXCL8 IL6 TNF
11 cryoglobulinemia 29.9 CRP CXCL8 IL10 IL6
12 ulcerative colitis 29.9 IL10 IL6 TNF
13 tarsal tunnel syndrome 29.9 CXCL8 IL10 TNF
14 uveitis 29.8 CCL2 ICAM1 TNF
15 hepatitis b 29.8 B2M CXCL8 IL10 TNF
16 granulomatous hepatitis 29.8 CRP F2 IL6
17 calcinosis 29.7 ALB B2M CCL2 CRP IL6 TNF
18 mycobacterium kansasii 29.7 CXCL8 TLR2 TNF
19 congenital diaphragmatic hernia 29.7 CXCL8 ICAM1
20 melioidosis 29.7 IL10 IL6 TLR2 TNF
21 asbestosis 29.6 CCL2 CXCL8 IL1B IL6 TNF
22 primary biliary cirrhosis 29.6 B2M IL10 IL6 TNF
23 ischemic heart disease 29.6 ALB CRP F2 IL6
24 lymphoma 29.6 ALB IL10 IL1B IL6 MEFV TNF
25 gallbladder cancer 29.5 ALB F2 IL6 TNF
26 angina pectoris 29.5 ALB CRP F2 IL6
27 pleural tuberculosis 29.5 ALB F2 IL6 TNF
28 arthus reaction 29.4 ADA ALB CRP IL1B TNF
29 colon adenocarcinoma 29.3 ALB CRP CXCL8 IL10 IL1B IL6
30 autoimmune hepatitis 29.2 CCL2 CRP ICAM1 IL1B TNF
31 lymphoblastic lymphoma 29.2 ALB F2 IL6 TNF
32 histiocytoma 29.0 CCL2 CXCL8 IL6
33 atherosclerosis 29.0 CCL2 CXCL8 IL10 IL1B IL6 MEFV
34 systemic lupus erythematosus 28.7 ALB CCL2 CRP ICAM1 IL10 IL6
35 choroiditis 28.4 ALB CCL2 CRP CXCL8 IL10 IL1B
36 rheumatoid arthritis 27.9 CCL2 CRP CXCL8 ICAM1 IL10 IL1B
37 von hippel-lindau syndrome 27.6 CCL2 CRP F2 ICAM1 IL1B IL6
38 pulmonary embolism 27.0 ADA ALB CCL2 CRP CXCL8 IL10
39 primary peritoneal carcinoma 12.2
40 benign multicystic peritoneal mesothelioma 12.2
41 peritoneal mesothelioma 12.1
42 disseminated peritoneal leiomyomatosis 12.1
43 tuberculous peritonitis 12.1
44 diphtheritic peritonitis 12.0
45 malignant peritoneal mesothelioma 11.9
46 peritoneal cystic mesothelioma 11.9
47 benign peritoneal mesothelioma 11.9
48 peritoneal serous papillary adenocarcinoma 11.9
49 acute female pelvic peritonitis 11.8
50 primary peritoneal serous/papillary carcinoma 11.8

Comorbidity relations with Peritonitis via Phenotypic Disease Network (PDN): (show all 13)


Active Peptic Ulcer Disease Acute Cystitis
Acute Kidney Failure Chronic Kidney Failure
Deficiency Anemia Familial Atrial Fibrillation
Heart Disease Intestinal Obstruction
Intestinal Perforation Mesenteric Artery Ischemia
Paralytic Ileus Protein-Energy Malnutrition
Respiratory Failure

Graphical network of the top 20 diseases related to Peritonitis:



Diseases related to Peritonitis

Symptoms & Phenotypes for Peritonitis

GenomeRNAi Phenotypes related to Peritonitis according to GeneCards Suite gene sharing:

26
id Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Synthetic lethal with MLN4924 (a NAE inhibitor) GR00250-A-1 9.77 IL1B TNF AQP1 CXCL8 F2 ICAM1
2 Synthetic lethal with MLN4924 (a NAE inhibitor) GR00250-A-2 9.77 IL1B TNF AQP1 CXCL8 F2 ICAM1

MGI Mouse Phenotypes related to Peritonitis:

44 (show all 11)
id Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 10.27 ADA AQP1 B2M CRP CXCL2 F2
2 hematopoietic system MP:0005397 10.25 ADA AQP1 B2M CD69 F2 ICAM1
3 homeostasis/metabolism MP:0005376 10.24 IL6 ITGAM LBP MEFV TLR2 TNF
4 immune system MP:0005387 10.2 ITGAM LBP MEFV TLR2 TNF ADA
5 cellular MP:0005384 10.18 ALB B2M CD69 ICAM1 IL10 IL6
6 digestive/alimentary MP:0005381 10.11 ALB B2M F2 ICAM1 IL10 IL6
7 endocrine/exocrine gland MP:0005379 10.09 ALB AQP1 B2M ICAM1 IL10 IL6
8 integument MP:0010771 9.91 ICAM1 IL10 IL1B IL6 MEFV TLR2
9 liver/biliary system MP:0005370 9.81 ADA ALB B2M IL10 IL6 LBP
10 neoplasm MP:0002006 9.56 ALB B2M ICAM1 IL10 IL1B IL6
11 skeleton MP:0005390 9.32 ADA AQP1 CD69 F2 IL10 IL1B

Drugs & Therapeutics for Peritonitis

Drugs for Peritonitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 253)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Ertapenem Approved, Investigational Phase 4,Phase 2 153832-46-3 150610
2
Mupirocin Approved, Investigational, Vet_approved Phase 4 12650-69-0 446596
3
Benzocaine Approved Phase 4 1994-09-7, 94-09-7 2337
4
Enalapril Approved, Vet_approved Phase 4 75847-73-3 5362032 40466924
5
Enalaprilat Approved Phase 4 76420-72-9 6917719
6
Hydralazine Approved Phase 4 86-54-4 3637
7
Losartan Approved Phase 4 114798-26-4 3961
8
Spironolactone Approved Phase 4 1952-01-7, 52-01-7 5833
9
Amoxicillin Approved, Vet_approved Phase 4,Phase 3 26787-78-0 33613 2171
10
Azithromycin Approved Phase 4 83905-01-5 55185 53477736 447043
11
Cefotaxime Approved Phase 4,Phase 3 63527-52-6 456256 5742673
12
Cefoxitin Approved Phase 4,Phase 3 35607-66-0 441199
13
Ciprofloxacin Approved, Investigational Phase 4,Phase 3,Phase 2 85721-33-1 2764
14
Imipenem Approved Phase 4,Phase 3 74431-23-5, 64221-86-9 104838
15
Vancomycin Approved Phase 4,Phase 2,Phase 3 1404-90-6 441141 14969
16
Norfloxacin Approved Phase 4,Phase 2,Phase 3 70458-96-7 4539
17
Propranolol Approved, Investigational Phase 4,Phase 3 525-66-6 4946
18
Metronidazole Approved Phase 4,Phase 3,Phase 2 443-48-1 4173
19
Cefazolin Approved Phase 4,Phase 3 25953-19-9 656510 33255
20
Ceftazidime Approved Phase 4,Phase 2,Phase 3 78439-06-2, 72558-82-8 5481173
21
Menthol Approved Phase 4 2216-51-5 16666
22
Icodextrin Approved, Investigational Phase 4,Phase 2 337376-15-5
23
Tigecycline Approved Phase 4,Phase 3 220620-09-7 5282044
24
Ceftriaxone Approved Phase 4,Phase 3 73384-59-5 5479530 5361919
25
Carvedilol Approved, Investigational Phase 4 72956-09-3 2585
26
Bacitracin Approved, Vet_approved Phase 4 1405-87-4 439542 10909430
27
Minocycline Approved, Investigational Phase 4,Phase 3 10118-90-8 5281021
28
Dexmedetomidine Approved, Vet_approved Phase 4 76631-46-4, 113775-47-6 68602 5311068 56032
29
Ampicillin Approved, Vet_approved Phase 4 69-53-4 6249
30
Sulbactam Approved Phase 4 68373-14-8
31
Aspirin Approved, Vet_approved Phase 4 50-78-2 2244
32
Dalteparin Approved Phase 4 9005-49-6
33
Dipyridamole Approved Phase 4 58-32-2 3108
34
Heparin Approved, Investigational Phase 4,Phase 2 9005-49-6 772 46507594
35 Nadroparin Approved Phase 4 9041-08-1
36
Warfarin Approved Phase 4 81-81-2 6691 54678486
37
Cefepime Approved Phase 4 88040-23-7 5479537
38
Acetylcysteine Approved, Investigational Phase 4,Phase 2,Phase 3 616-91-1 12035
39
Lenograstim Approved Phase 4,Phase 2,Phase 3 135968-09-1
40
Chlorhexidine Approved, Vet_approved Phase 4 55-56-1 9552079 2713
41
Pentoxifylline Approved, Investigational Phase 4 6493-05-6 4740
42
Caspofungin Approved Phase 4 179463-17-3, 162808-62-0 468682 2826718
43
Micafungin Approved, Investigational Phase 4 235114-32-6 3081921 477468
44
Miconazole Approved, Investigational, Vet_approved Phase 4 22916-47-8 4189
45
Dalbavancin Approved Phase 4 91097-81-3, 171500-79-1 122186
46
Teicoplanin Approved Phase 4 61036-62-2
47 tannic acid Approved, Nutraceutical Phase 4
48
Angiotensin II Investigational Phase 4 68521-88-0, 4474-91-3, 11128-99-7 172198 65143
49 Sultamicillin Investigational Phase 4 76497-13-7
50 Anti-Bacterial Agents Phase 4,Phase 2,Phase 3

Interventional clinical trials:

(show top 50) (show all 211)

id Name Status NCT ID Phase Drugs
1 Randomized Comparison of Two Albumin Administration Schedules for Spontaneous Bacterial Peritonitis (SBP) Unknown status NCT00761098 Phase 4 Standard Care;Experimental
2 Probiotics Use in the Chronic Peritoneal Dialysis Patients Unknown status NCT01076426 Phase 4 Pro-biotics
3 Antibiotics Versus Surgery in Acute Appendicitis Unknown status NCT01421901 Phase 4 Ertapenem
4 Topical Gentamicin Cream Versus Alternating Gentamicin and Mupirocin Cream in Peritoneal Dialysis Unknown status NCT00751374 Phase 4 gentamicin;gentamicin cream alternating with mupirocin cream
5 The Effect of Enalapril and Losartan on Peritoneal Membrane in Continuous Ambulatory Peritoneal Dialysis Patients Unknown status NCT01041963 Phase 4 Enalapril;Enalapril plus Losartan;Placebo
6 Comparison the Level of CTGF Protein and Related Cytokine in Pleural Effusion Unknown status NCT00313066 Phase 4
7 Empirical vs 2nd Line Antibiotic Therapy in Health-care Associated Infections in Cirrhosis Unknown status NCT01820026 Phase 4 Imipenem;Vancomycin;azithromycin;Cefotaxime;Amoxicillin
8 Prospective Comparison of Primary Abdominal Closure and Vacuum Assisted Laparostomy in Treatment of Severe Peritonitis Completed NCT01531543 Phase 4
9 Bacteria Endotoxin in Peritoneal Dialysis Effluent as a Predictor of Relapsing, Recurrent, and Repeat Peritonitis Completed NCT01817309 Phase 4
10 Effect of Icodextrin on the Treatment Outcome of Peritoneal Dialysis Patients During Acute Peritonitis Completed NCT01044446 Phase 4 Icodextrin;glucose-based peritoneal dialysate
11 Norfloxacin In The Primary Prophylaxis Of Spontaneous Bacterial Peritonitis Completed NCT00359853 Phase 4 Oral norfloxacin
12 Health Economic Assessment of Tygacil® in the Treatment of Secondary Peritonitis in Intensive Care Units (ICUs) Completed NCT00481962 Phase 4 Tygacil
13 Norfloxacin Versus Ciprofloxacin for Spontaneous Bacterial Peritonitis (SBP) Prevention Completed NCT01542801 Phase 4 Norfloxacin;ciprofloxacin
14 Randomized Controlled Trial Comparing Residual Kidney Function in Patients Undergoing Three or Four Exchanges CAPD Completed NCT01637792 Phase 4
15 Comparison of Efficacy of Cefotaxime, Ceftriaxone, and Ciprofloxacin for the Treatment of SBP in Patients With LC Completed NCT01265173 Phase 4 Cefotaxime;Ceftriaxone;Ciprofloxacin
16 Open Label Trial to Establish the Equivalence Between ANDY-Disc® and Ultrabag® in Patients on CAPD. Completed NCT00255619 Phase 4
17 Beneficial Effect of Probiotics on Chronic Kidney Disease Completed NCT01391468 Phase 4
18 Study on B-blockers to Prevent Decompensation of Cirrhosis With HTPortal Completed NCT01059396 Phase 4 propranolol;carvedilol;placebo
19 Use of Ointments in Prevention of Catheter Related Infections in PD Completed NCT00400595 Phase 4 Mupirocin ointment;Polysporin Triple
20 Omega-3 Fatty Acids and Postoperative Complications After Colorectal Surgery Completed NCT00488904 Phase 4
21 Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection Completed NCT00195351 Phase 4 tigecycline;ceftriaxone sodium + metronidazole
22 Administration of pH-Neutral Peritoneal Dialysis Solutions Containing Lactate or Bicarbonate in Children Completed NCT01632046 Phase 4 lactate and bicarbonate buffered dialysis solutions
23 Dexmedetomidine for Sepsis in ICU Randomized Evaluation Trial Completed NCT01760967 Phase 4 Dexmedetomidine
24 T.E.A. Study Three Days Ertapenem Versus Three Days Ampicillin- Sulbactam Completed NCT00630513 Phase 4 Ertapenem;Ampicillin-Sulbactam
25 Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection (cIAI) Completed NCT00230971 Phase 4 tigecycline;ceftriaxone plus metronidazole
26 The Effect of Neutral Peritoneal Dialysis (PD) Solution With Minimal Glucose-Degradation-Product (GDP) on Fluid Status and Body Composition Completed NCT00966615 Phase 4
27 Warfarin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy and Azygoportal Disconnection Completed NCT02247414 Phase 4 Warfarin;Dipyridamole;Aspirin;Low Molecular Weight Heparin
28 Effect of Glucose Degradation Products (GDP) on Endothelial Dysfunction Completed NCT01315314 Phase 4 Balance, Fresenius Medical Care, Germany
29 IV Antibiotics With Lavage for Severe PD Peritonitis Recruiting NCT02926846 Phase 4 Intravenous vancomycin & gentamicin with adjunctive lavage;Intraperitoneal vancomycin & gentamicin
30 Comparing Cefepime Versus Cefazolin Plus Ceftazidime for CAPD-associated Peritonitis Recruiting NCT02872038 Phase 4 Cefepime;Cefazolin plus Ceftazidime
31 PROPHYlactic Implantation of BIOlogic Mesh in Peritonitis (PROPHYBIOM) Recruiting NCT02277262 Phase 4
32 The Efficacy of Prolonged Antibiotic Therapy for the Prevention of Relapsing Peritonitis in Peritoneal Dialysis Patients With High Dialysis Effluent Bacterial DNA Fragment Levels Recruiting NCT02593201 Phase 4 Extended antibiotics (cefazolin or ceftazidime);Usual antibiotics (cefazolin or ceftazidime)
33 FEcal Transplant, a Hope to Eradicate Colonization of Patient Harboring eXtreme Drug Resistant Bacteria? Recruiting NCT03029078 Phase 4 fecal microbiota transplant
34 Extended Antibiotic Therapy in Postoperative of Laparoscopic Cholecystectomy in Acute Cholecystitis Recruiting NCT02057679 Phase 4 Amoxicillin clavulanic;Placebo
35 G-CSF Plus NAC In Severe Alcoholic Hepatitis Recruiting NCT02971306 Phase 4 standard medical therapy;G-CSF;n-Acetylcysteine
36 Chlorhexidine Gluconate Versus Mupirocin Ointment in the Prevention of Peritoneal Dialysis-Related Infection Recruiting NCT02547103 Phase 4
37 Warfarin Prevents Portal Vein Thrombosis in Liver Cirrhotic Patients With Hypersplenism After Laparoscopic Splenectomy Recruiting NCT02238444 Phase 4 Warfarin;Dipyridamole;Aspirin;Low Molecular Weight Heparin
38 Straight Versus Coiled Peritoneal Dialysis Catheter for Peritoneal Dialysis Patients Recruiting NCT02479295 Phase 4
39 Initial Non-operative Treatment Strategy Versus Appendectomy Treatment Strategy for Simple Appendicitis in Children Recruiting NCT02848820 Phase 4 Augmentin + Gentamicin
40 The Effect of Branched-chain Amino Acid on the Improvement of Serum Albumin Level in Cirrhotic Patients With Ascites Recruiting NCT02755701 Phase 4 Branched-chain Amino Acid;Placebo
41 Pharmacokinetic Study on Echinocandins for Patients With Septic Shock Following Secondary Peritonitis Not yet recruiting NCT02805049 Phase 4 Echinocandins
42 Evaluation of Intravenous and Intraperitoneal Pharmacokinetics of Dalbavancin in Peritoneal Dialysis Patients Not yet recruiting NCT02940730 Phase 4 Dalbavancin via Intravenous Administration;Dalbavancin via Intraperitoneal Administration
43 Clinical, Inflammatory, and Economic Impact of Dextran 70 in Treating Spontaneous Bacterial Peritonitis Terminated NCT00570960 Phase 4 Dextran 70
44 The INFECIR-2 Albumin Prevention Study Terminated NCT02034279 Phase 4 Albumin
45 Method of Exit Site Care in Chronic Peritoneal Dialysis Patients Terminated NCT00416338 Phase 4
46 ICULIP, Influence of Two Lipid Emulsions in the Nosocomial Infection in Critical Patients Terminated NCT00396461 Phase 4 MCT/LCT (1:1);MCT/LCT/omega-3 (5:4:1)
47 Cefoperazone/Sulbactam In The Treatment Of Serious Intra-Abdominal And Hepatobiliary Infections. Withdrawn NCT00463762 Phase 4 CP-75385-02 Cefoperazone/sulbactam
48 Laparoscopic Peritoneal Lavage or Resection for Generalised Peritonitis for Perforated Diverticulitis Unknown status NCT01317485 Phase 3
49 Role of Probiotics in the Prevention of Spontaneous Bacterial Peritonitis in Cirrhotic Patients: A Randomized Placebo Control Trial Unknown status NCT00678613 Phase 2, Phase 3 Probiotics and Placebo;Probiotics and Norfloxacin
50 Moxifloxacin Plus Metronidazole Versus Piperacillin/Tazobactam for the Treatment of Patients With Intra-abdominal Abscesses Unknown status NCT00629135 Phase 3 Moxifloxacin/Metronidazole or Piperacillin/Tazobactam

Search NIH Clinical Center for Peritonitis

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Genetic Tests for Peritonitis

Anatomical Context for Peritonitis

MalaCards organs/tissues related to Peritonitis:

39
Liver, Colon, Endothelial, Kidney, Neutrophil, Monocytes, Appendix

Publications for Peritonitis

Articles related to Peritonitis:

(show top 50) (show all 4802)
id Title Authors Year
1
Image Findings of Rare Case of Peritoneal Carcinomatosis from Non Small Cell Lung Cancer and Response to Erlotinib in F-18 FDG Positron Emission Tomography/Computed Tomography. ( 28533646 )
2017
2
Chronic peritoneal inflammation and nodules masquerading as peritoneal carcinomatosis in Birt-Hogg-Dube syndrome. ( 28470670 )
2017
3
Current management strategies for peritoneal mesothelioma. ( 28664790 )
2017
4
Pasteurella multocida Bacteremia and Peritonitis in a Patient With Cirrhosis: A Life-Threatening Case From a Prick of a Cactus. ( 28890902 )
2017
5
The association between soluble intercellular adhesion molecule-1 levels in drained dialysate and peritoneal injury in peritoneal dialysis. ( 28201944 )
2017
6
Non-traumatic acute peritonitis in children: causes and prognosis in 226A patients at the National Hospital of Zinder, Niger. ( 28947401 )
2017
7
MiR-136 inhibits gastric cancer-specific peritoneal metastasis by targeting HOXC10. ( 28656883 )
2017
8
Tuberculous peritonitis diagnosed with the help of 18a88F-FDG PET/CT scan. ( 28247520 )
2017
9
A Case of Tuberculous Peritonitis Presenting as Small Bowel Obstruction. ( 28539036 )
2017
10
Toll-like receptor-2 Arg753Gln and Arg677Trp polymorphisms and susceptibility to pulmonary and peritoneal tuberculosis. ( 28332241 )
2017
11
Clostridium tertium Peritonitis and Concurrent Bacteremia in a Patient With a History of Alcoholic Cirrhosis. ( 28944228 )
2017
12
A study of peritoneal metastatic xenograft model of colorectal cancer in the treatment of hyperthermic intraperitoneal chemotherapy with Raltitrexed. ( 28535418 )
2017
13
Peritoneal encapsulationA -A an unexpected cause of acute intestinal obstruction. ( 28688775 )
2017
14
DDR2 Expression Is Associated with a High Frequency of Peritoneal Dissemination and Poor Prognosis in Colorectal Cancer. ( 28476831 )
2017
15
Presentation of a malignant peritoneal mesothelioma in the forma of rough hepatic calcifications. ( 28480727 )
2017
16
Long-term regional chemotherapy for patients with epithelial malignant peritoneal mesothelioma results in improved survival. ( 28189456 )
2017
17
High Levels of Soluble C5b-9 Complex in Dialysis Fluid May Predict Poor Prognosis in Peritonitis in Peritoneal Dialysis Patients. ( 28046064 )
2017
18
First description of spontaneous fungal peritonitis caused by Fusarium solani in a critically ill patient with liver cirrhosis. ( 28948024 )
2017
19
Peritonitis outcomes in patients with HIV and end-stage renal failure on peritoneal dialysis: a prospective cohort study. ( 28158991 )
2017
20
A case of disseminated peritoneal leiomyomatosis after two laparoscopic procedures due to uterine fibroids. ( 28446940 )
2017
21
Unusual presentation of a late-onset recurrence of malignant peritoneal mesothelioma. ( 28264807 )
2017
22
Case report of myeloperoxidase deficiency associated with disseminated paracoccidioidomycosis and peritoneal tuberculosis. ( 28954085 )
2017
23
Hydrocele Caused by Peritoneal Fluid Leakage Through Inguinal Canal. ( 28512168 )
2017
24
Peritoneal inflammation and fibrosis in C-reactive protein transgenic mice undergoing peritoneal dialysis solution treatment. ( 26857687 )
2017
25
Discontinuation of Peritoneal Dialysis after Late Initiation of Eculizumab in a Case of Familial Atypical Hemolytic-Uremic Syndrome: A Case Report. ( 28612003 )
2017
26
Group A Streptococcal Peritonitis and Toxic Shock Syndrome in a Postmenopausal Woman. ( 28824068 )
2017
27
First-line chemotherapy with pemetrexed plus cisplatin for malignant peritoneal mesothelioma. ( 28594258 )
2017
28
Malignant peritoneal mesothelioma, clear cell variant, in a female and its differentiation from clear cell carcinoma. ( 28215643 )
2017
29
The MicroRNA-199a/214 Cluster Targets E-Cadherin and Claudin-2 and Promotes High Glucose-Induced Peritoneal Fibrosis. ( 28428333 )
2017
30
Mesorhizobium peritonitis: The first reported case. ( 28004488 )
2017
31
PET/CT for differentiating between tuberculous peritonitis and peritoneal carcinomatosis: The parietal peritoneum. ( 28079823 )
2017
32
Fungal infection control by garlic extracts (Allium sativum L.) and modulation of peritoneal macrophages activity in murine model of sporotrichosis. ( 28492800 )
2017
33
Derivation and validation of a prognostic model for postoperative risk stratification of critically ill patients with faecal peritonitis. ( 28900902 )
2017
34
Drugs, doses, and durations of intraperitoneal chemotherapy: standardising HIPEC and EPIC for colorectal, appendiceal, gastric, ovarian peritoneal surface malignancies and peritoneal mesothelioma. ( 28540826 )
2017
35
Uremic cardiomyopathy and peritoneal transport in incident peritoneal dialysis patients in the west of Mexico. ( 28946968 )
2017
36
Peritoneal tuberculosis in patients with rheumatoid arthritis undergoing adalimumab treatment. ( 28527603 )
2017
37
Abnormal peritoneal regulation of chemokine activation-The role of IL-8 in pathogenesis of endometriosis. ( 28120482 )
2017
38
A randomised, open-label, phase 2 study of the IDO1 inhibitor epacadostat (INCB024360) versus tamoxifen as therapy for biochemically recurrent (CA-125 relapse)-only epithelial ovarian cancer, primary peritoneal carcinoma, or fallopian tube cancer. ( 28698009 )
2017
39
Diffuse peritoneal mesothelioma: A case series of 62 patients including paraoccupational exposures to chrysotile asbestos. ( 28940402 )
2017
40
Peritoneal Mesothelioma with Residential Asbestos Exposure. Report of a Case with Long Survival (Seventeen Years) Analyzed by Cgh-Array. ( 28829357 )
2017
41
Successful treatment of chronic hepatitis C virus infection in a patient receiving daily peritoneal dialysis. ( 28947525 )
2017
42
Clinicoepidemiological profile of peritonitis complicating acute peritoneal dialysis: A single-center experience. ( 28937074 )
2017
43
Hereditary Angioedema: An Overlooked Cause of Recurrent Abdominal Pain and Free Peritoneal Fluid. ( 28780207 )
2017
44
Treatment of Peritoneal Dissemination in Stomach Cancer Patients With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Rationale and Design of the PERISCOPE Study. ( 28705789 )
2017
45
Peritoneal recurrence of thymoma treated by surgery and hyperthermic intraperitoneal chemotherapy. ( 28838398 )
2017
46
Pubic osteomyelitis after surgery for perforated colonic diverticulitis with fecal peritonitis: A case report. ( 28735117 )
2017
47
Immunohistochemical staining with non-phospho I^-catenin as a diagnostic and prognostic tool of COX-2 inhibitor therapy for patients with extra-peritoneal desmoid-type fibromatosis. ( 28851389 )
2017
48
Multicystic peritoneal mesothelioma: A short review. ( 28528021 )
2017
49
Rifaximin versus norfloxacin for prevention of spontaneous bacterial peritonitis: a systematic review. ( 28944070 )
2017
50
Multicenter Phase II Study of Intravenous and Intraperitoneal Paclitaxel With S-1 for Pancreatic Ductal Adenocarcinoma Patients With Peritoneal Metastasis. ( 28059968 )
2017

Variations for Peritonitis

Expression for Peritonitis

Search GEO for disease gene expression data for Peritonitis.

Pathways for Peritonitis

Pathways related to Peritonitis according to GeneCards Suite gene sharing:

(show top 50) (show all 57)
id Super pathways Score Top Affiliating Genes
1
Show member pathways
14.11 B2M CCL2 CRP CXCL2 CXCL8 ICAM1
2
Show member pathways
13.6 CCL2 CXCL8 F2 ICAM1 IL10 IL1B
3
Show member pathways
13.49 CCL2 CXCL2 CXCL8 IL10 IL1B IL6
4
Show member pathways
13.46 B2M CCL2 CXCL2 CXCL8 ICAM1 IL10
5
Show member pathways
13.33 CCL2 CXCL2 CXCL8 IL10 IL1B IL6
6
Show member pathways
13.09 CCL2 CXCL2 CXCL8 IL1B IL6 MEFV
7
Show member pathways
12.99 CCL2 CXCL8 IL10 IL1B IL6 LBP
8
Show member pathways
12.96 B2M CXCL8 ICAM1 IL10 IL1B IL6
9
Show member pathways
12.91 CCL2 CXCL8 ICAM1 IL1B IL6 TLR2
10
Show member pathways
12.69 CCL2 F2 IL10 IL1B IL6 TNF
11
Show member pathways
12.65 IL10 IL1B IL6 TLR2 TNF
12 12.65 B2M CCL2 IL10 IL1B TLR2 TNF
13
Show member pathways
12.46 CCL2 CXCL2 CXCL8 IL1B IL6 TLR2
14
Show member pathways
12.37 CXCL8 IL1B IL6 LBP TNF
15
Show member pathways
12.36 IL10 IL1B ITGAM TLR2 TNF
16
Show member pathways
12.32 CXCL8 IL1B IL6 LBP TLR2 TNF
17 12.32 IL10 IL1B IL6 ITGAM LBP TLR2
18 12.29 CXCL8 IL10 IL1B IL6 TNF
19
Show member pathways
12.27 CXCL8 IL10 IL1B IL6 TNF
20 12.15 CCL2 ICAM1 IL1B TNF
21 12.12 CD69 IL10 IL6 ITGAM TNF
22 12.09 CCL2 CXCL2 ICAM1 IL1B IL6 TNF
23
Show member pathways
12.08 IL10 IL1B IL6 TLR2 TNF
24 12.04 CCL2 CXCL8 ICAM1 IL1B IL6 TNF
25 12.01 CXCL2 CXCL8 ICAM1 IL1B LBP TNF
26 12 AQP1 CCL2 CXCL2 CXCL8 ICAM1 IL1B
27 11.99 IL1B IL6 ITGAM TNF
28 11.97 CXCL2 CXCL8 IL1B IL6 LBP
29
Show member pathways
11.96 CXCL8 ICAM1 IL6 LBP
30 11.93 CXCL8 IL10 IL1B IL6 ITGAM TLR2
31 11.91 IL10 IL1B IL6 ITGAM TNF
32 11.89 IL10 IL1B ITGAM TNF
33 11.87 ICAM1 IL10 IL6 TLR2 TNF
34 11.87 CCL2 CXCL8 ICAM1 IL1B IL6 TLR2
35 11.87 CCL2 CXCL8 ICAM1 IL10 IL1B IL6
36 11.85 CXCL8 IL10 IL1B IL6 ITGAM TNF
37 11.81 CXCL8 ICAM1 IL6
38 11.73 CCL2 CXCL2 CXCL8 IL1B IL6 TNF
39
Show member pathways
11.71 CXCL2 CXCL8 ICAM1 IL1B IL6 TNF
40 11.67 CCL2 IL1B ITGAM TLR2 TNF
41 11.65 ICAM1 IL6 ITGAM TNF
42 11.64 ICAM1 IL10 ITGAM
43 11.54 IL1B IL6 TNF
44 11.54 CXCL2 CXCL8 IL1B IL6 ITGAM TLR2
45 11.53 CXCL8 ICAM1 ITGAM
46 11.49 IL10 IL1B IL6 TNF
47 11.48 ICAM1 IL10 IL1B IL6 TNF
48 11.41 CCL2 CXCL8 IL6
49 11.39 CXCL2 IL10 IL1B IL6 TNF
50 11.38 IL1B IL6 TNF

GO Terms for Peritonitis

Cellular components related to Peritonitis according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 extracellular region GO:0005576 9.97 ALB B2M CCL2 CRP CXCL2 CXCL8
2 cell surface GO:0009986 9.8 ADA B2M ICAM1 ITGAM LBP TLR2
3 extracellular space GO:0005615 9.53 ADA ALB B2M CCL2 CRP CXCL2
4 external side of plasma membrane GO:0009897 9.5 ADA B2M CD69 F2 ICAM1 IL6
5 extracellular exosome GO:0070062 10.02 ALB AQP1 B2M CRP F2 ICAM1

Biological processes related to Peritonitis according to GeneCards Suite gene sharing:

(show top 50) (show all 58)
id Name GO ID Score Top Affiliating Genes
1 aging GO:0007568 9.99 ADA CCL2 IL10 IL6
2 response to hypoxia GO:0001666 9.99 ADA CCL2 ICAM1 TLR2
3 regulation of cell shape GO:0008360 9.97 CCL2 F2 ICAM1 IL6
4 positive regulation of NF-kappaB transcription factor activity GO:0051092 9.96 ICAM1 IL1B IL6 TLR2 TNF
5 cellular response to tumor necrosis factor GO:0071356 9.94 CCL2 CXCL8 ICAM1 IL6
6 positive regulation of sequence-specific DNA binding transcription factor activity GO:0051091 9.93 IL10 IL1B IL6 TNF
7 cellular response to organic cyclic compound GO:0071407 9.9 CCL2 IL1B TNF
8 response to wounding GO:0009611 9.9 CCL2 F2 IL6
9 cellular response to interleukin-1 GO:0071347 9.9 CCL2 CXCL8 ICAM1 IL6
10 chemokine-mediated signaling pathway GO:0070098 9.89 CCL2 CXCL2 CXCL8
11 cellular response to drug GO:0035690 9.89 CCL2 CD69 IL1B
12 response to insulin GO:0032868 9.89 ICAM1 IL10 IL6 TLR2
13 defense response to Gram-positive bacterium GO:0050830 9.89 CRP IL6 LBP TLR2 TNF
14 neutrophil chemotaxis GO:0030593 9.88 CCL2 CXCL8 IL1B
15 response to glucocorticoid GO:0051384 9.88 CCL2 IL10 IL6 TNF
16 humoral immune response GO:0006959 9.87 CCL2 IL6 TNF
17 positive regulation of tumor necrosis factor production GO:0032760 9.85 CCL2 LBP TLR2
18 positive regulation of nitric oxide biosynthetic process GO:0045429 9.84 ICAM1 IL1B IL6 TNF
19 cellular response to estradiol stimulus GO:0071392 9.83 CCL2 IL10 IL6
20 protein kinase B signaling GO:0043491 9.83 CCL2 IL1B TNF
21 acute-phase response GO:0006953 9.83 CRP F2 IL6 LBP
22 response to amino acid GO:0043200 9.82 CCL2 ICAM1 IL6
23 cellular response to dexamethasone stimulus GO:0071549 9.81 AQP1 CCL2 ICAM1 IL6
24 positive regulation of neutrophil chemotaxis GO:0090023 9.8 CXCL2 CXCL8 LBP
25 positive regulation of interleukin-6 production GO:0032755 9.8 IL1B IL6 LBP TLR2 TNF
26 cellular response to lipopolysaccharide GO:0071222 9.8 CCL2 CXCL8 ICAM1 IL10 IL6 LBP
27 positive regulation of NF-kappaB import into nucleus GO:0042346 9.79 IL1B TLR2 TNF
28 embryonic digestive tract development GO:0048566 9.78 ADA CXCL8 TNF
29 positive regulation of interleukin-8 production GO:0032757 9.78 IL1B LBP TLR2 TNF
30 response to lipopolysaccharide GO:0032496 9.76 CCL2 CXCL2 ICAM1 IL10 IL1B IL6
31 negative regulation of growth of symbiont in host GO:0044130 9.75 IL10 LBP TNF
32 positive regulation of heterotypic cell-cell adhesion GO:0034116 9.74 IL10 IL1B TNF
33 positive regulation of chemokine production GO:0032722 9.73 IL6 LBP TLR2 TNF
34 cellular response to lipoteichoic acid GO:0071223 9.72 LBP TLR2
35 positive regulation of chemokine biosynthetic process GO:0045080 9.72 IL1B TNF
36 negative regulation of lipid storage GO:0010888 9.72 CRP IL6 TNF
37 lipopolysaccharide-mediated signaling pathway GO:0031663 9.72 CCL2 IL1B LBP TLR2 TNF
38 opsonization GO:0008228 9.71 CRP LBP
39 endothelial cell apoptotic process GO:0072577 9.7 IL10 TNF
40 regulation of establishment of endothelial barrier GO:1903140 9.7 IL1B TNF
41 positive regulation of cellular extravasation GO:0002693 9.68 CCL2 ICAM1
42 positive regulation of leukocyte adhesion to vascular endothelial cell GO:1904996 9.68 ICAM1 TNF
43 negative regulation of cytokine secretion involved in immune response GO:0002740 9.68 IL10 TNF
44 epithelial cell proliferation involved in salivary gland morphogenesis GO:0060664 9.68 IL6 TNF
45 positive regulation of fever generation GO:0031622 9.67 IL1B TNF
46 sequestering of triglyceride GO:0030730 9.66 IL1B TNF
47 regulation of vascular endothelial growth factor production GO:0010574 9.66 CCL2 IL6
48 receptor biosynthetic process GO:0032800 9.64 IL10 TNF
49 positive regulation of calcidiol 1-monooxygenase activity GO:0060559 9.63 IL1B TNF
50 response to molecule of bacterial origin GO:0002237 9.35 B2M CXCL2 CXCL8 IL10 TLR2

Molecular functions related to Peritonitis according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 chemokine activity GO:0008009 9.43 CCL2 CXCL2 CXCL8
2 lipopeptide binding GO:0071723 9.32 LBP TLR2
3 cytokine activity GO:0005125 9.17 CCL2 CXCL2 CXCL8 IL10 IL1B IL6
4 lipopolysaccharide binding GO:0001530 9.13 F2 LBP TLR2
5 protein binding GO:0005515 10.11 ADA ALB AQP1 B2M CD69 CRP

Sources for Peritonitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....